Skip to main content

Peer Review reports

From: Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study

Original Submission
5 Jul 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Sep 2023 Reviewed Reviewer Report - Fanggang Ren
19 Nov 2023 Reviewed Reviewer Report
24 Nov 2023 Author responded Author comments - Yuslina Mat Yusoff
Resubmission - Version 3
24 Nov 2023 Submitted Manuscript version 3
25 Nov 2023 Reviewed Reviewer Report
10 Feb 2024 Author responded Author comments - Yuslina Mat Yusoff
Resubmission - Version 4
10 Feb 2024 Submitted Manuscript version 4
15 Feb 2024 Author responded Author comments - Yuslina Mat Yusoff
Resubmission - Version 5
15 Feb 2024 Submitted Manuscript version 5
9 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
15 Apr 2024 Editorially accepted
20 Apr 2024 Article published 10.1186/s13104-024-06772-1

You can find further information about peer review here.

Back to article page